Alexander Gelbard
Last active: 1/25/2017


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Tracheocutaneous fistula repair with autologous auricular cartilage cap graft. Yawn RJ, Yawn JR, Gelbard A, Wootten CT (2016) Laryngoscope 126(9): 2085-8
    › Primary publication · 27297140 (PubMed)
  2. Idiopathic subglottic stenosis is associated with activation of the inflammatory IL-17A/IL-23 axis. Gelbard A, Katsantonis NG, Mizuta M, Newcomb D, Rotsinger J, Rousseau B, Daniero JJ, Edell ES, Ekbom DC, Kasperbauer JL, Hillel AT, Yang L, Garrett CG, Netterville JL, Wootten CT, Francis DO, Stratton C, Jenkins K, McGregor TL, Gaddy JA, Blackwell TS, Drake WP (2016) Laryngoscope 126(11): E356-E361
    › Primary publication · 27296163 (PubMed) · PMC5077677 (PubMed Central)
  3. Molecular analysis of idiopathic subglottic stenosis for Mycobacterium species. Gelbard A, Katsantonis NG, Mizuta M, Newcomb D, Rotsinger J, Rousseau B, Daniero JJ, Edell ES, Ekbom DC, Kasperbauer JL, Hillel AT, Yang L, Garrett CG, Netterville JL, Wootten CT, Francis DO, Stratton C, Jenkins K, McGregor TL, Gaddy JA, Blackwell TS, Drake WP (2017) Laryngoscope 127(1): 179-185
    › Primary publication · 27295947 (PubMed) · PMC5156582 (PubMed Central)
  4. Dysphagia Following Airway Reconstruction in Adults. Lennon CJ, Gelbard A, Bartow C, Garrett CG, Netterville JL, Wootten CT (2016) JAMA Otolaryngol Head Neck Surg 142(1): 20-4
    › Primary publication · 26561927 (PubMed)
  5. Novel application of the Sonopet for endoscopic posterior split and cartilage graft laryngoplasty. Yawn RJ, Daniero JJ, Gelbard A, Wootten CT (2016) Laryngoscope 126(4): 941-4
    › Primary publication · 26541889 (PubMed)
  6. Disease homogeneity and treatment heterogeneity in idiopathic subglottic stenosis. Gelbard A, Donovan DT, Ongkasuwan J, Nouraei SA, Sandhu G, Benninger MS, Bryson PC, Lorenz RR, Tierney WS, Hillel AT, Gadkaree SK, Lott DG, Edell ES, Ekbom DC, Kasperbauer JL, Maldonado F, Schindler JS, Smith ME, Daniero JJ, Garrett CG, Netterville JL, Rickman OB, Sinard RJ, Wootten CT, Francis DO (2016) Laryngoscope 126(6): 1390-6
    › Primary publication · 26536285 (PubMed) · PMC6198250 (PubMed Central)
  7. Severe bradycardia associated with suspension laryngoscopy. Latuska RF, Kuhl NO, Garrett CG, Berry JM, Gelbard A (2016) Laryngoscope 126(4): 949-50
    › Primary publication · 26526978 (PubMed)
  8. Predictors of Posterior Glottic Stenosis: A Multi-Institutional Case-Control Study. Hillel AT, Karatayli-Ozgursoy S, Samad I, Best SR, Pandian V, Giraldez L, Gross J, Wootten C, Gelbard A, Akst LM, Johns MM, North American Airway Collaborative (NoAAC) (2016) Ann Otol Rhinol Laryngol 125(3): 257-63
    › Primary publication · 26466860 (PubMed) · PMC4742396 (PubMed Central)
  9. Unleashing rapamycin in fibrosis. Hillel AT, Gelbard A (2015) Oncotarget 6(18): 15722-3
    › Primary publication · 26158293 (PubMed) · PMC4599220 (PubMed Central)
  10. Effect of injection augmentation on need for framework surgery in unilateral vocal fold paralysis. Francis DO, Williamson K, Hovis K, Gelbard A, Merati AL, Penson DF, Netterville JL, Garrett CG (2016) Laryngoscope 126(1): 128-34
    › Primary publication · 26153268 (PubMed) · PMC4704988 (PubMed Central)
  11. Causes and consequences of adult laryngotracheal stenosis. Gelbard A, Francis DO, Sandulache VC, Simmons JC, Donovan DT, Ongkasuwan J (2015) Laryngoscope 125(5): 1137-43
    › Primary publication · 25290987 (PubMed) · PMC4562418 (PubMed Central)
  12. Impact of race/ethnicity on laryngeal cancer in patients treated at a Veterans Affairs Medical Center. Sandulache VC, Kubik MW, Skinner HD, Malsky JA, Gelbard AH, Zevallos JP (2013) Laryngoscope 123(9): 2170-5
    › Primary publication · 23729204 (PubMed)
  13. Molecular profiling of sinonasal undifferentiated carcinoma. Gelbard A, Hale KS, Takahashi Y, Davies M, Kupferman ME, El-Naggar AK, Myers JN, Hanna EY (2014) Head Neck 36(1): 15-21
    › Primary publication · 23633104 (PubMed) · PMC3874284 (PubMed Central)
  14. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Takahashi Y, Kupferman ME, Bell D, Jiffar T, Lee JG, Xie TX, Li NW, Zhao M, Frederick MJ, Gelbard A, Myers JN, Hanna EY (2012) Clin Cancer Res 18(22): 6178-87
    › Primary publication · 23032744 (PubMed) · PMC3513379 (PubMed Central)
  15. Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo. Liu C, Lewis CM, Lou Y, Xu C, Peng W, Yang Y, Gelbard AH, Lizée G, Zhou D, Overwijk WW, Hwu P (2012) J Immunother 35(3): 276-82
    › Primary publication · 22421945 (PubMed) · PMC3860320 (PubMed Central)
  16. Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Li HS, Gelbard A, Martinez GJ, Esashi E, Zhang H, Nguyen-Jackson H, Liu YJ, Overwijk WW, Watowich SS (2011) Blood 118(14): 3879-89
    › Primary publication · 21828128 (PubMed) · PMC3193265 (PubMed Central)
  17. An information theoretic, microfluidic-based single cell analysis permits identification of subpopulations among putatively homogeneous stem cells. Glotzbach JP, Januszyk M, Vial IN, Wong VW, Gelbard A, Kalisky T, Thangarajah H, Longaker MT, Quake SR, Chu G, Gurtner GC (2011) PLoS One 6(6): e21211
    › Primary publication · 21731674 (PubMed) · PMC3120839 (PubMed Central)
  18. Antitumor activity mediated by CpG: the route of administration is critical. Lou Y, Liu C, Lizée G, Peng W, Xu C, Ye Y, Rabinovich BA, Hailemichael Y, Gelbard A, Zhou D, Overwijk WW, Hwu P (2011) J Immunother 34(3): 279-88
    › Primary publication · 21389870 (PubMed) · PMC6119202 (PubMed Central)
  19. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB (2010) Clin Cancer Res 16(9): 2550-61
    › Primary publication · 20388845 (PubMed) · PMC2936966 (PubMed Central)
  20. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Sikora AG, Gelbard A, Davies MA, Sano D, Ekmekcioglu S, Kwon J, Hailemichael Y, Jayaraman P, Myers JN, Grimm EA, Overwijk WW (2010) Clin Cancer Res 16(6): 1834-44
    › Primary publication · 20215556 (PubMed) · PMC2858983 (PubMed Central)
  21. IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity. Sikora AG, Jaffarzad N, Hailemichael Y, Gelbard A, Stonier SW, Schluns KS, Frasca L, Lou Y, Liu C, Andersson HA, Hwu P, Overwijk WW (2009) J Immunol 182(12): 7398-407
    › Primary publication · 19494262 (PubMed) · PMC2774140 (PubMed Central)
  22. Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. Thapa P, Zhang G, Xia C, Gelbard A, Overwijk WW, Liu C, Hwu P, Chang DZ, Courtney A, Sastry JK, Wang PG, Li C, Zhou D (2009) Vaccine 27(25-26): 3484-8
    › Primary publication · 19200815 (PubMed) · PMC5772602 (PubMed Central)
  23. An orthotopic murine model of sinonasal malignancy. Gelbard A, Kupferman ME, Jasser SA, Chen W, El-Naggar AK, Myers JN, Hanna EY (2008) Clin Cancer Res 14(22): 7348-57
    › Primary publication · 19010850 (PubMed) · PMC5428892 (PubMed Central)
  24. Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects. Chakraborty M, Gelbard A, Carrasquillo JA, Yu S, Mamede M, Paik CH, Camphausen K, Schlom J, Hodge JW (2008) Cancer Immunol Immunother 57(8): 1173-83
    › Primary publication · 18256832 (PubMed)
  25. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006) Clin Cancer Res 12(6): 1897-905
    › Primary publication · 16551875 (PubMed) · PMC1865094 (PubMed Central)